The first question has largely been answered by a 4-year trial with finasteride. This study showed that BPH is a progressive condition that can lead to a worsening of symptoms, acute urinary ...

Debruyne et al. [69] conducted a multicenter, randomized study of 1051 patients with BPH. Patients received ER alfuzosin 5 mg twice daily, finasteride 5 mg daily, or both drugs for six months.

D'Amico AV and Roehrborn CG (2007) Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Lancet Oncol ...

Finasteride is one of two 5-alpha reductase ... androgenic alopecia or male pattern hair loss), as well as an enlarged ...

Finasteride has two FDA-approved usages. One is to help treat benign prostatic hyperplasia (aka enlarged prostate). Second, finasteride, a 5-alpha-reductase, helps promote hair growth by blocking ...

The goals of therapy for BPH are to ameliorate LUTS, prevent related complications, and achieve measurable improvement in the patient's QOL. 3 In addition to drug and resource utilization costs ...

Molecular studies of the PCPT...should allow personalized prevention of prostate cancer with finasteride Uniquely, the PCPT was designed to ascertain its primary endpoint (detection of prostate ...